Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.340
-0.090 (-2.03%)
Aug 12, 2026, 3:44 PM EDT - Market open
IMDX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.67 | 4.06 | 1.88 | 1.5 | 0.96 | 2.2 | |
Revenue Growth | -60.77% | 115.58% | 25.15% | 56.89% | -56.42% | 80.76% |
Cost of Revenue | 0.86 | 1.76 | 1.14 | 1.09 | 0.98 | 0.78 |
Gross Profit | 0.81 | 2.3 | 0.74 | 0.41 | -0.02 | 1.42 |
Selling, General & Admin | 18.73 | 16.98 | 14.15 | 13.98 | 23.01 | 22.84 |
Research & Development | 19.15 | 15.9 | 9.84 | 9.29 | 7.3 | 5.04 |
Other Operating Expenses | -1.37 | 20.55 | 37.79 | 2.28 | -12.34 | 27.27 |
Total Operating Expenses | 36.51 | 53.42 | 61.78 | 25.55 | 17.98 | 55.15 |
Operating Income | -50.3 | -51.12 | -61.04 | -25.14 | -18 | -53.73 |
Interest Expense | -0.1 | -0.11 | -0.08 | -0.05 | -0.08 | - |
Other Non-Operating Income (Expense) | 1.04 | 1.01 | 0.46 | 0.33 | -0.53 | 0.85 |
Total Non-Operating Income (Expense) | 0.94 | 0.9 | 0.38 | 0.28 | -0.62 | 0.85 |
Pretax Income | -10.85 | -50.22 | -60.66 | -24.86 | -18.61 | -96.48 |
Provision for Income Taxes | - | - | - | - | - | -9.26 |
Net Income | -49.36 | -50.22 | -60.66 | -27.78 | -72.9 | -64.1 |
Net Income Attributable to Preferred Dividends | - | - | - | - | 0.52 | - |
Earnings From Discontinued Operations | - | - | - | -2.93 | -54.29 | -20.49 |
Net Income to Common | -49.36 | -50.22 | -60.66 | -27.78 | -146.32 | -128.19 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 34 | 30 | 13 | 8 | 6 | 4 |
Shares Outstanding (Diluted) | 34 | 30 | 13 | 8 | 6 | 4 |
Shares Change | 52.42% | 133.16% | 70.84% | 38.10% | 24.61% | 35.80% |
EPS (Basic) | -1.49 | -1.65 | -4.66 | -3.75 | -3.45 | -14.40 |
EPS (Diluted) | -1.49 | -1.65 | -4.66 | -3.75 | -3.45 | -14.40 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31 | -25.37 | -21.21 | -23.61 | -49.91 | -38.19 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.92 | -0.83 | -1.62 | -3.09 | -9.01 | -8.59 |
Gross Margin | 48.32% | 56.67% | 39.34% | 27.48% | -1.88% | 64.60% |
Operating Margin | -3011.86% | -1260.76% | -3245.14% | -1672.39% | -1878.60% | -2444.27% |
Profit Margin | -2955.63% | -1238.52% | -3225.04% | -1848.37% | -7609.81% | -2916.15% |
FCF Margin | -1856.23% | -625.62% | -1127.33% | -1570.59% | -5209.60% | -1737.40% |
EBITDA | -47.86 | -48.93 | -59.48 | -23.46 | -12.78 | -49.52 |
EBITDA Margin | -2865.57% | -1206.58% | -3161.99% | -1560.61% | -1333.72% | -2252.96% |
EBIT | -50.3 | -51.12 | -61.04 | -25.14 | -18 | -53.73 |
EBIT Margin | -3011.86% | -1260.76% | -3245.14% | -1672.39% | -1878.60% | -2444.27% |
Effective Tax Rate | - | 0.00% | 0.00% | 0.00% | 0.00% | 9.60% |